Use of and Investigation with Drugs, Biologics, Devices, or Test Articles under FDA Regulations- POL021
Abstract: Clinical investigations involving human subjects and drugs, biologics, devices or test articles are subject to review. In order to comply with federal regulations, the IRB will determine what types of applications and exemptions (when applicable) are required for the study. This document describes various types of studies and instructions for submission and compliance.
Effective Date: 3/30/2007
Review/Revised Date: 2/21/2018
Category: Research
Policy Owner: Vice President for Research Policy Contact: